In-Orbit Performance of the GRACE Follow-on Laser Ranging Interferometer.

The Laser Ranging Interferometer (LRI) instrument on the Gravity Recovery and Climate Experiment (GRACE) Follow-On mission has provided the first laser interferometric range measurements between remote spacecraft, separated by approximately 220 km. Autonomous controls that lock the laser frequency to a cavity reference and establish the 5 degrees of freedom two-way laser link between remote spacecraft succeeded on the first attempt. Active beam pointing based on differential wave front sensing compensates spacecraft attitude fluctuations.

Higher-order Laguerre-Gauss modes in (non-) planar four-mirror cavities for future gravitational wave detectors.

One of the limiting noise sources in the current generation of gravitational wave detectors, such as the advanced laser interferometer gravitational wave observatory (aLIGO), is the thermal noise in the interferometer's test mass coatings. One proposed method to reduce the coupling of this noise source to the gravitational wave readout is using a laser beam in the higher-order spatial LG mode within the interferometer. Here we show that the current four-mirror cavities of aLIGO are not compatible with Laguerre-Gauss modes due to astigmatism.

Novel technique for thermal lens measurement in commonly used optical components.

The absorption of light in transmissive optics cause a thermally induced effect known as thermal lensing. This effect provokes an often undesired change of a laser beam transmitted by the optic. In this paper we present a measurement method that allows us to determine thermal lensing in commonly used optical components.

Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis.

The Eph receptor A2 (EphA2) is overexpressed in a range of human epithelial cancers, a phenotype that is associated with cancer cell proliferation, progression and angiogenesis. Mouse models of mammary neoplasia have confirmed the role of EphA2 as mice carrying a knockout allele of EphA2 were resistant to breast cancer, a phenotype that was associated with interactions between EphA2 and ErbB2. We investigated in vivo the role of EphA2 in GI cancer.